Obalon Therapeutics

Last update: Yesterday

United States (USA) Its 13 main executives

Recent executive movements at Obalon Therapeutics

William Plovanic, who was Chief Financial Officer and President, is promoted to President and Chief Executive Officer  (news posted on October 24 2019).
Nooshin Hussainy, who was Vice President of Finance, is promoted to Chief Financial Officer  (news posted on October 24 2019).

Create an alert
to follow the executive moves at Obalon Therapeutics.

Latest M&A news in Biotechnology.

Pionyr Immunotherapeutics and Gilead Sciences have announced they will merge (posted on Jun 23, 2020).
Invitae has announced the acquisition of Archerdxinc (posted on Jun 23, 2020).
Ocuphire has announced the acquisition of Rexahn Pharmaceuticals (posted on Jun 19, 2020).

Latest news about Obalon Therapeutics

Obalon Therapeutics on Wikipedia, Google News & Yahoo Finance

Obalon Therapeutics on LinkedIn, Twitter & YouTube

Obalon Therapeutics has 1,415 competitors including Aptuit (United States (USA)), Eurofins (France) and Genentech (United States (USA)).

The most constantly updated executive directory.



Learn about your clients' org charts. Understand their industries and their competitors.



View the executives' biographies. Contact the executives through our email platform.



Select key words to follow your clients. Receive alerts when executive movements happen.


Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.